{"count": 2, "results": [{"_id": "24855121", "pmid": 24855121, "title": "Simvastatin increases the in vivo activity of the first-line tuberculosis regimen.", "journal": "J Antimicrob Chemother", "authors": ["Skerry C", "Pinn ML", "Bruiners N", "Pine R", "Gennaro ML", "Karakousis PC"], "date": "2014-09-01T00:00:00Z", "doi": "10.1093/jac/dku166", "meta_date_publication": "2014 Sep", "meta_volume": "69", "meta_issue": "9", "meta_pages": "2453-7", "score": 50068.7, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ increases the in vivo activity of the first-line @<m>DISEASE_Tuberculosis</m> @DISEASE_MESH:D014376 @@@tuberculosis@@@ regimen.", "citations": {"NLM": "Skerry C, Pinn ML, Bruiners N, Pine R, Gennaro ML, Karakousis PC. Simvastatin increases the in vivo activity of the first-line tuberculosis regimen. J Antimicrob Chemother. 2014 Sep;69(9):2453-7. PMID: 24855121", "BibTeX": "@article{24855121, title={Simvastatin increases the in vivo activity of the first-line tuberculosis regimen.}, author={Skerry C and Pinn ML and Bruiners N and Pine R and Gennaro ML and Karakousis PC}, journal={J Antimicrob Chemother}, volume={69}, number={9}, pages={2453-7}}"}}, {"_id": "31616387", "pmid": 31616387, "pmcid": "PMC6764081", "title": "Simvastatin Enhances the Immune Response Against Mycobacterium tuberculosis", "journal": "Front Microbiol", "authors": ["Guerra-De-Blas PDC", "Bobadilla-Del-Valle M", "Sada-Ovalle I", "Estrada-García I", "Torres-González P", "López-Saavedra A", "Guzmán-Beltrán S", "Ponce-de-León A", "Sifuentes-Osornio J"], "date": "2019-09-20T00:00:00Z", "doi": "10.3389/fmicb.2019.02097", "meta_date_publication": "2019", "meta_volume": "10", "meta_issue": "", "meta_pages": "2097", "score": 50068.547, "text_hl": "These results demonstrate that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ activates several immune mechanisms that favor the containment of @<m>DISEASE_Tuberculosis</m> @DISEASE_MESH:D014376 @@@M. tuberculosis infection@@@, providing relevant evidence to consider statins as candidates for host-directed therapy. ", "citations": {"NLM": "Guerra-De-Blas PDC, Bobadilla-Del-Valle M, Sada-Ovalle I, Estrada-García I, Torres-González P, López-Saavedra A, Guzmán-Beltrán S, Ponce-de-León A, Sifuentes-Osornio J. Simvastatin Enhances the Immune Response Against Mycobacterium tuberculosis Front Microbiol. 2019;10():2097. PMID: 31616387", "BibTeX": "@article{31616387, title={Simvastatin Enhances the Immune Response Against Mycobacterium tuberculosis}, author={Guerra-De-Blas PDC and Bobadilla-Del-Valle M and Sada-Ovalle I and Estrada-García I and Torres-González P and López-Saavedra A and Guzmán-Beltrán S and Ponce-de-León A and Sifuentes-Osornio J}, journal={Front Microbiol}, volume={10}, pages={2097}}"}}]}